Literature DB >> 22275299

Synthesis and evaluation of 1-amino-6-halo-β-carbolines as antimalarial and antiprion agents.

Mark J Thompson1, Jennifer C Louth, Susan M Little, Matthew P Jackson, Yohan Boursereau, Beining Chen, Iain Coldham.   

Abstract

Malaria is one of the world's most devastating parasitic diseases, causing almost one million deaths each year. Growing resistance to classical antimalarial drugs, such as chloroquine, necessitates the discovery of new therapeutic agents for successful control of this global disease. Here, we report the synthesis of some 6-halo-β-carbolines as analogues of the potent antimalarial natural product, manzamine A, retaining its heteroaromatic core whilst providing compounds with much improved synthetic accessibility. Two compounds displayed superior activity to chloroquine itself against a resistant Plasmodium falciparum strain, identifying them as promising leads for future development. Furthermore, in line with previous reports of similarities in antimalarial and antiprion effects of aminoaryl-based antimalarial agents, the 1-amino-β-carboline libraries were also found to possess significant bioactivity against a prion-infected cell line.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22275299     DOI: 10.1002/cmdc.201200002

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  3 in total

1.  Development of Kinase-Selective, Harmine-Based DYRK1A Inhibitors that Induce Pancreatic Human β-Cell Proliferation.

Authors:  Kunal Kumar; Peng Wang; Roberto Sanchez; Ethan A Swartz; Andrew F Stewart; Robert J DeVita
Journal:  J Med Chem       Date:  2018-08-21       Impact factor: 7.446

2.  A novel way to grow hemozoin-like crystals in vitro and its use to screen for hemozoin inhibiting antimalarial compounds.

Authors:  Vincent Thomas; Ana Góis; Bruce Ritts; Peter Burke; Thomas Hänscheid; Gerald McDonnell
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

3.  Characterization and optimization of the haemozoin-like crystal (HLC) assay to determine Hz inhibiting effects of anti-malarial compounds.

Authors:  Carolina Tempera; Ricardo Franco; Carlos Caro; Vânia André; Peter Eaton; Peter Burke; Thomas Hänscheid
Journal:  Malar J       Date:  2015-10-12       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.